Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines. - El-Tanani M; Satyam SM; Rabbani SA; El-Tanani Y; Sutherland M; Muhana F (PloS one, 2025)